What is the target INR range for patients on Warfarin?

What is the target INR range for patients on Warfarin?

• A. 1.0-2.0
• B. 2.0-3.0
• C. 3.0-4.0
• D. 4.0-5.0

Answer: (B)

The target INR range for patients on Warfarin is primarily between 2.0 and 3.0, which is considered the standard range for most indications, such as atrial fibrillation and venous thromboembolism. This range is established to effectively prevent thromboembolic events while minimizing the risk of bleeding complications. In certain clinical scenarios, such as patients with mechanical heart valves or recurrent thromboembolism, the target INR may be adjusted higher, typically between 2.5 and 3.5, but even higher ranges typically do not exceed 4.0 due to the increased risk of hemorrhage at those levels. Hence, while options might suggest higher ranges, they are generally reserved for specific cases under close supervision. The INR range of 1.0-2.0 is generally too low for therapeutic anticoagulation, failing to provide adequate protection against clot formation. An INR range of 3.0-4.0 or 4.0-5.0 is often associated with a greater risk for bleeding, making these levels inappropriate for most patients unless specifically indicated and monitored closely. Thus, the choice of 2.0-3.0 aligns with clinical guidelines for safe and effective Warfarin

The target INR range for patients on Warfarin is primarily between 2.0 and 3.0, which is considered the standard range for most indications, such as atrial fibrillation and venous thromboembolism. This range is established to effectively prevent thromboembolic events while minimizing the risk of bleeding complications.

In certain clinical scenarios, such as patients with mechanical heart valves or recurrent thromboembolism, the target INR may be adjusted higher, typically between 2.5 and 3.5, but even higher ranges typically do not exceed 4.0 due to the increased risk of hemorrhage at those levels. Hence, while options might suggest higher ranges, they are generally reserved for specific cases under close supervision.

The INR range of 1.0-2.0 is generally too low for therapeutic anticoagulation, failing to provide adequate protection against clot formation. An INR range of 3.0-4.0 or 4.0-5.0 is often associated with a greater risk for bleeding, making these levels inappropriate for most patients unless specifically indicated and monitored closely. Thus, the choice of 2.0-3.0 aligns with clinical guidelines for safe and effective Warfarin